- Jan 7, 2025
- 2
- 0
- 1
- School/Org
- University of Waterloo, School of Optometry & Vision Science
- City
- Waterloo
- State
- ON
CONTEMPORARY MANAGEMENT OF PRIMARY OPEN ANGLE GLAUCOMA
Sarah MacIver BSc, OD, FAAO
This lecture will explore modern challenges in managing primary open-angle glaucoma (POAG) using a case-based approach. It will highlight contemporary medical therapies, including new medications like selective Rho kinase inhibitors and prostaglandin analogs, which offer improved efficacy and fewer side effects.
Additionally, it will address the impact of preservatives such as benzalkonium chloride (BAK) on ocular surface disease (OSD) and provide strategies to reduce these effects. The session will also cover interventional options, such as laser treatments and minimally invasive glaucoma surgeries (MIGS), to optimize patient outcomes.
--
CEwire2025 Live Dates: January 25, April 5, June 7, September 6, 2025
Time: 1:15PM - 2:15PM ET
Location: Virtual Room 3
Credit Hours: 1
Synchronous COPE ID: 95063-GL
Asynchronous COPE ID: 95065-GL
--
[DOWNLOAD HANDOUT] and DISCUSS THIS LECTURE & ASK QUESTIONS BELOW!
Sarah MacIver BSc, OD, FAAO
This lecture will explore modern challenges in managing primary open-angle glaucoma (POAG) using a case-based approach. It will highlight contemporary medical therapies, including new medications like selective Rho kinase inhibitors and prostaglandin analogs, which offer improved efficacy and fewer side effects.
Additionally, it will address the impact of preservatives such as benzalkonium chloride (BAK) on ocular surface disease (OSD) and provide strategies to reduce these effects. The session will also cover interventional options, such as laser treatments and minimally invasive glaucoma surgeries (MIGS), to optimize patient outcomes.
--
CEwire2025 Live Dates: January 25, April 5, June 7, September 6, 2025
Time: 1:15PM - 2:15PM ET
Location: Virtual Room 3
Credit Hours: 1
Synchronous COPE ID: 95063-GL
Asynchronous COPE ID: 95065-GL
--
[DOWNLOAD HANDOUT] and DISCUSS THIS LECTURE & ASK QUESTIONS BELOW!
